comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · escrs marrakech...

22
K. Stjepanek, J. Hienert, M. Ruiß, N. Hirnschall, O. Findl Comparison of visual performance of 2 diffractive trifocal intraocular lenses: a randomised controlled trial Vienna Institute for Research in Ocular Surgery (VIROS) Hanusch Krankenhaus, Vienna, Austria

Upload: others

Post on 30-Jun-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

K. Stjepanek, J. Hienert, M. Ruiß, N. Hirnschall, O. Findl

Comparison of visual performance of 2 diffractive trifocal intraocular lenses: a randomised controlled trial

Vienna Institute for Research in Ocular Surgery (VIROS)Hanusch Krankenhaus, Vienna, Austria

Page 2: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Financial Disclosure

ESCRS Marrakech 2020

Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:• Aerie• Alcon• Bausch + Lomb• Carl Zeiss Meditec AG• Cristalens• Croma Pharma

O. Findl - Scientific Advisor / Member of Scientific Advisory Board:• Alcon• Carl Zeiss Meditec AG• Croma Pharma• Johnson & Johnson Vision Care• Merck

Personal financial interest in products:• None

• Heidelberg Engineering• Johnson & Johnson Vision Care• Novartis• Oculentis• Rayner• Roche

Page 3: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Trifocal IOLs

ESCRS Marrakech 2020

Page 4: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Comparison of the two study lenses

ESCRS Marrakech 2020

RayOne Trifocal AT LISA tri 839 MP

4.5mm diffractivetrifocal zone

>4.5mm monofocal, distance

4.34mm diffractivetrifocal zone

>4.34mm bifocalzone

Page 5: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Study design

• randomized, double-masked trial• 88 eyes of 44 patients

• one eye AT LISA tri 839 MP (Zeiss)• other eye RayOne Trifocal (Rayner)

− randomized assignment of IOL

ESCRS Marrakech 2020

Page 6: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Inclusion criteria• Senile cataract

• Scheduled cataract surgery for both eyes

• Motivated to be less spectacle dependent

• ≥ 21 years

• Corneal astigmatism ≤ 1.5 D (keratometry, IOL Master)

Exclusion criteria• Pregnancy

• Retinitis pigmentosa, chronic uveitis, amblyopia

• Pupil misalignment > 1mm

• Previous LASIK / retinal surgery

ESCRS Marrakech 2020

Page 7: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Methods

• Main outcome

• Change of uncorrected near visual acuity (UNVA)

• Secondary outcome

• Uncorrected and best corrected distant visual acuity (UCDVA, BCDVA)• Uncorrected and distance corrected intermediate visual acuity (UCIVA, BIVA)• Distance corrected near visual acuity (DCNVA)• Defocus curve• Salzburg reading desk• Aston halometer• Contrast sensibility in miosis and mydriasis• Quality of vision questionnaire

ESCRS Marrakech 2020

Page 8: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Uncorrected VA

ESCRS Marrakech 2020

logM

ARn = 40

Ray One TrifocalAT LISA tri

p=0.707 p=0.460 p=0.327

Page 9: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Distance corrected VA

ESCRS Marrakech 2020

logM

AR

p=0.527 p=0.519 p=0.193

n = 40Ray One TrifocalAT LISA tri

Page 10: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

RayOne Trifocal AT LISA tri

-4 -3.5 -3 -2.5 -2 -1.5 -1 -0.5 0 0.5 1 1.5 2

Defocus curvelo

gMAR

diopters

p=0.167

p=0.016p=0.121

-0.10.0 0.10.20.30.40.50.6

ESCRS Marrakech 2020

Page 11: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Salzburg Reading Desk

seco

nds

wor

dspe

r min

ute

p=0.633 p=0.258

ESCRS Marrakech 2020

Page 12: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Aston Halometer

halo

-rad

ius

TRI018 ODAT LISA tri

TRI018 OS RayOne Trifocal

2.5

2.0

1.5

1.0

0.5

0.0

ESCRS Marrakech 2020

0° 45° 90° 135° 180° 225° 270° 315°

RayOne Trifocal AT LISA trip=0.434

Page 13: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

ESCRS Marrakech 2020

OPTEC 6500 Vision TesterPhotopic Mesopic

RayOneTrifocal AT LISA tri RayOne

Trifocal AT LISA tri

Miosis13.5 ( ± 5.9) 17.3 ( ± 7.4) 8.7 ( ± 4.7) 12.0 ( ± 4.9)

p= 0.493 p= 0.082

Miosis +Glare

14.1 ( ± 6.7) 16.2 ( ± 7.0) 4.6 ( ± 4.8) 5.2 ( ± 5,3)

p=0.808 p=0.790

Mydriasis9.0 ( ± 5.9) 12.3 ( ± 7,1) 6.8 ( ± 4.4) 9.6 ( ± 4.6)

p= 0.293 p= 0.297

Mydriasis +Glare

6.3 ( ± 5.7) 9.0 ( ± 7.5) 0.2 ( ± 1.0) 1.4 ( ± 2.5)

p= 0.691 p= 0.159

Page 14: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Decentration

RayOne Trifocal AT Lisa tri

Mean 0.92 0.94

SD ± 0.32 ± 0.23

p = 0.465

ESCRS Marrakech 2020

Page 15: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Tilt

RayOne Trifocal AT Lisa tri

Mean 3.09 3.20

SD ± 0.91 ± 0.94

p = 0.779

ESCRS Marrakech 2020

Page 16: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Quality of vision

ESCRS Marrakech 2020

Page 17: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Quality of vision

05

10152025303540

glarehaloes

starburst

s

hazy vision

blurred vi

sion

distorti

on

multiple im

ages

fluctu

ation of v

ision

focusin

g diffi

cultie

s

depth perceptio

n

never occasionally quite often very often

patie

nts

ESCRS Marrakech 2020

Page 18: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Severity

05

1015202530

glare haloes starbursts hazy vision blurred visionnot at all mild moderate severe

patie

nts

ESCRS Marrakech 2020

Page 19: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Bothersome

05

1015202530

glare haloes starbursts hazy vision blurred vision

not at all a little quite very

patie

nts

ESCRS Marrakech 2020

Page 20: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Subjective Disturbance of Vision

ESCRS Marrakech 2020

-10 -8 -6 -4 -2 0 2 4 6 8 10

Subjective Distant Visual Acuity p=0,20

Subjective Intermediate Visual Acuity p=0,26

Subjective Near Visual Acuity p=0,37

Subjective Halo p=0,43

Subjective Glare p=0,63

Subjective Starbursts. p=0,34

Overall Disturbance p=0,67Ray One Trifocal AT LISA trin=23

Page 21: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

Conclusions

RayOne Trifocal showed…

• trend for slightly better UCNVA and DCNVA

• significantly better VA in intermediate zone in defocus curve

• no significant difference concerning dysphotopsia

ESCRS Marrakech 2020

Page 22: Comparison of visual performance of 2 diffractive trifocal … · 2020-03-26 · ESCRS Marrakech 2020 Sponsored Clinical Trials & Unrestricted Grants to Institute (VIROS) in 2020:

ESCRS Marrakech 2020

www.viros.at